An unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma

Toby A. Eyre, Leyla Mohseninejad, Lianne Barnieh, Kaijun Wang, Yiran He, Keri Yang, Rhys Williams, Bijal D. Shah

Open source

DOI: 10.1080/13696998.2026.2696131
Published: 2026-07-14
Container: Journal of Medical Economics
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/13696998.2026.2696131,
  title = {An unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma},
  author = {Toby A. Eyre and Leyla Mohseninejad and Lianne Barnieh and Kaijun Wang and Yiran He and Keri Yang and Rhys Williams and Bijal D. Shah},
  year = {2026},
  journal = {Journal of Medical Economics},
  doi = {10.1080/13696998.2026.2696131},
  url = {https://doi.org/10.1080/13696998.2026.2696131}
}

RIS

TY  - JOUR
TI  - An unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma
AU  - Toby A. Eyre
AU  - Leyla Mohseninejad
AU  - Lianne Barnieh
AU  - Kaijun Wang
AU  - Yiran He
AU  - Keri Yang
AU  - Rhys Williams
AU  - Bijal D. Shah
PY  - 2026
JO  - Journal of Medical Economics
DO  - 10.1080/13696998.2026.2696131
UR  - https://doi.org/10.1080/13696998.2026.2696131
ER  -

APA

Eyre, T. A., Mohseninejad, L., Barnieh, L., Wang, K., He, Y., Yang, K., Williams, R., & Shah, B. D. (2026). An unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma. Journal of Medical Economics. https://doi.org/10.1080/13696998.2026.2696131

Source records

crossref · retrieved 2026-09-25T22:07:32.011Z